Literature DB >> 9892946

Phototesting prior to narrowband (TL-01) ultraviolet B phototherapy.

P M Gordon1, P J Saunders, B L Diffey, P M Farr.   

Abstract

A device for phototesting patients prior to narrowband phototherapy is described. One hundred and fifty patients (130 with psoriasis and 20 with eczema) of skin types I-IV were phototested on the forearm and 22 on both forearm and back. The minimal erythema dose (MED) was judged visually 24 h after irradiation, and in those patients who were tested at two body sites, objective measurement of the erythema was made using a reflectance instrument. The MED values on the arm showed a fivefold range. There was no significant association between skin type and MED. The MED values on the arm were significantly higher than those measured on the back, although the differences were small in the majority of cases. No significant difference was found between the slopes of the dose-response curves measured on the arm and on the back.

Entities:  

Mesh:

Year:  1998        PMID: 9892946     DOI: 10.1046/j.1365-2133.1998.02505.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  Spectral effects of UV on psoriasis.

Authors:  Sophie C Weatherhead; Peter M Farr; Nicholas J Reynolds
Journal:  Photochem Photobiol Sci       Date:  2013-01       Impact factor: 3.982

2.  A Rapid and Cost-Effective Device for Testing Minimal Erythema Dose.

Authors:  Leah Conant; Kristen M Beck; Wilson Liao
Journal:  Dermatol Ther (Heidelb)       Date:  2018-08-10

3.  The erythema Q-score, an imaging biomarker for redness in skin inflammation.

Authors:  John Frew; Lauren Penzi; Mayte Suarez-Farinas; Sandra Garcet; Patrick M Brunner; Tali Czarnowicki; Jaehwan Kim; Claire Bottomley; Robert Finney; Inna Cueto; Judilyn Fuentes-Duculan; Hanako Ohmatsu; Tim Lentini; Valerie Yanofsky; James G Krueger; Emma Guttman-Yassky; Daniel Gareau
Journal:  Exp Dermatol       Date:  2020-11-30       Impact factor: 3.960

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.